{"path":"Images/Pasted image 20240314142059.png","text":"LVEF needs to be supranormal (> 0.6) Regurgitant flow occurs in diastole (Issues }+{_Forward flow improved by low SVR . Anticoagulation Rx AF common (in 75%) Systemic embolirisk Endocarditis prophylaxis NOT routinely required Acute vs chronic__Different aetiology and pathophysiology Mild: < 30% (Gen) Fatigue Moderate: 30 to 60% | MR severity based on regurgitant fraction S8S | Dyspnoea Severe: > 60% History. Palpitation Careful epidural can be tolerated \\ Functional capacity (NYHA ciass) Arterial line for BP AF o Association TOE onsider â€”onitoring Pulmonary hypertension PA catheter Displaced and forceful apex Ephedrine preferred Soft $1, Loud $3 prctee et woe - : Avoid vasoconstictors | Assessment Ascultation Loudest in apex N gs Mitral regurgitation (MR) - Pansystolic murmur Inotroplo drugs - der R Radiating to axilla Pulmonary vasodilators oG Pmitale fin sinus ytm) Consider IABP in acute severe MR AR o 1ABP = Inira-aortic balloon pump Consultation LA/LV enlargement oXR N Mitral annular calcification 290 bpm ity of MR Adequate preload Other valvular abnormali Echo (Goais) Pulmonary artery systolic pressure Hypercarbia LV function and dimension Hypoxia idosi Consider MV repair / MVR prior to elective surg Acidosis Acute severe MR ymptomatic but normal LV Optimisation LVEF <06 Indications Asymptomatic but LV dysfunction Severe MR End-systolic dimension 2 40mm New AF Significant pulmonary hypertension","libVersion":"0.3.2","langs":"eng"}